From PCOS to PMOS: Why the Name Change Matters
For years, millions of women have been diagnosed with Polycystic Ovary Syndrome (PCOS), a name that has long created confusion. Despite the term and the visual of the “polycystic ovaries” in question ultrasound scans actually show small immature follicles (egg-containing sacs) that began developing but never fully matured, mistaken as cysts.
This misunderstanding is one reason the condition is now transitioning: Polyendocrine Metabolic Ovarian Syndrome (PMOS)
The change reflects a major shift in how medical professionals understand the condition. While the old name focused attention on the ovaries, the new name recognises that this is often a broader hormonal and metabolic condition involving multiple systems throughout the body.
Breaking down PMOS:
- Polyendocrine: multiple hormone systems are involved
- Metabolic: insulin and metabolism play an important role
- Ovarian: the ovaries are involved, but they are only one piece of the picture
So what is actually happening?
In many cases, follicles begin developing normally, but hormonal signals become disrupted because the internal environment is not ideal. Factors such as insulin resistance, elevated androgen activity, stress hormones, inflammation, and genetics can interfere with the normal process of follicle maturation and ovulation.
Instead of: Follicles → one dominant follicle → ovulation
The pattern may become: Follicles → hormonal disruption → stalled development
The issue is often not that the ovaries are “producing bad eggs.” Rather, the hormonal environment may be preventing normal development. This shift matters because it changes the question from:
"What is wrong with my ovaries?" to: "What systems are influencing my hormones and metabolism?"
The broader perspective should encourage a more functional approach, looking beyond symptoms alone and considering the root of the problem (insulin patterns, sleep, stress, nutrition, inflammation, and overall hormonal health).
Another reason for the shift away from a purely ovarian-focused name is that researchers have noticed similar metabolic and hormonal patterns in some male relatives of women with PCOS/PMOS. While men do not develop ovarian symptoms, they may show related features such as insulin resistance, early balding, acne, altered androgen patterns, or increased metabolic risk. This has strengthened the idea that the condition may involve broader inherited hormonal and metabolic pathways, not just the ovaries alone.
A Functional Approach to PMOS
From a functional perspective, PMOS management focuses on creating an internal environment that supports healthier hormone signaling and metabolic function. Helpful lifestyle strategies may include regular movement (particularly resistance training and walking), prioritizing protein-rich balanced meals to support blood sugar stability, improving sleep quality, and reducing chronic stress. Nutrients and supplements commonly explored include magnesium, vitamin D (if deficient), omega-3 fatty acids, and iron where heavy periods contribute to low iron stores. Supplements with emerging evidence in PMOS/PCOS include Myo-inositol (often combined with D-chiro-inositol) for insulin sensitivity and ovulation support, and N-acetyl cysteine (NAC) for metabolic and antioxidant support. The goal is not to “force” the ovaries to function, but to support the hormonal environment and metabolic systems influencing them.
Bisous X
Disclaimer: PMOS is a complex condition with multiple possible drivers, and no single approach works for everyone. Supplements and lifestyle changes should be individualised and ideally guided by appropriate testing and healthcare advice. Functional strategies are intended to support overall health and address potential underlying contributors, not replace medical evaluation, prescribed treatment, or individualized care.